Results 41 to 50 of about 48,929 (237)

Association of insulin resistance, insulin and leptin levels with coronary in-stent restenosis

The Egyptian Heart Journal, 2012
Background: In-stent restenosis remains the major limitation of coronary stent implantation. Leptin is a hormone strongly related to insulin resistance (IR).
Amira Shoukry, Islam El-Sherbieny, Enas Swelam   +2 more
doaj   +1 more source

Comparison of 2 Different Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis

JACC: Asia, 2022
Background Drug-coated balloons (DCBs) offer an effective treatment for in-stent restenosis (ISR). The Genoss DCB is a novel paclitaxel-coated balloon with a shellac plus vitamin E excipient that enhances drug delivery to the target lesion, minimizing ...
E. Jun, Eun-Seok Shin, S. Yuan, Y. Bhak, S. Garg, W. Kang, Je Sang Kim, June-Hong Kim, J. Bae, S. Rha, I. Chae   +10 more
semanticscholar   +1 more source

Research advances in the etiology of in-stent restenosis of coronary arteries. [PDF]

Front Cardiovasc Med
This article conducts a systematic literature analysis, focusing on exploring the etiological factors of coronary in—stent restenosis(ISR). It is found that the occurrence of ISR is influenced by a variety of factors, including patient—related biological
Bai H, Zhang B, Sun Y, Wang X, Luan B, Zhang X.   +5 more
europepmc   +2 more sources

A novel Nanocellulose-Gelatin-AS-IV external stent resists EndMT by activating autophagy to prevent restenosis of grafts

Bioactive Materials, 2023
Vein grafts are widely used for coronary artery bypass grafting and hemodialysis access, but restenosis remains the ''Achilles' heel'' of these treatments.
Tianshu Chu, Qingye Li, Chun Dai, Xiang Li, Xiang Kong, Yangming Fan, Hongyan Yin, Jianjun Ge   +7 more
doaj   +1 more source

Plasma Proteome Profiling of Patients With In-stent Restenosis by Tandem Mass Tag-Based Quantitative Proteomics Approach

Frontiers in Cardiovascular Medicine, 2022
Background Despite the widespread application of new drug-eluting stents, a considerable portion of patients experience in-stent restenosis (ISR). To date, the pathophysiologic mechanisms of ISR remain poorly understood.
J. Hou, Qiaoting Deng, Sudong Liu, Xiaohong Qiu, Xunwei Deng, W. Zhong, Z. Zhong   +6 more
semanticscholar   +1 more source

In-Stent Ulceration: An Unusual Pathology

Case Reports in Cardiology, 2014
In-stent restenosis occurs in 10–60% of cases undergoing interventional therapy. Many mechanisms explain the reason for in-stent restenosis, but restenosis due to an ulcerated plaque is very rare and has not been well reported in the literature.
Jagadeesh Kumar Kalavakunta, Shravan Gangula, Vishal Gupta   +2 more
doaj   +1 more source

The predictive value of preprocedural laboratory data in patients with coronary artery restenosis in various types of stents

Российский кардиологический журнал, 2019
Aim. To identify the effect of preprocedural laboratory parameters on the occurrence of in-stent restenosis in various types of stents, to assess the significance of gender, age and various forms of coronary artery disease (CAD) as risk factors for ...
D. V. Shames, A. S. Galyavich, Z. M. Galeeva, L. V. Baleeva   +3 more
doaj   +1 more source

Defining Key Features of Complex Coronary Lesions: An Evidence Based Review of Clinical Practice. Part II: Chronic Total Occlusions, Graft Interventions, In-Stent Restenosis, and Antithrombotic Strategies

Reviews in cardiovascular medicine, 2022
Clinicians have long recognized that certain features of coronary artery lesions increase the complexity of intervention. Complex lesions are associated with worse cardiovascular outcomes and a higher risk of subsequent ischemic events. These lesions are
Daniel Feldman, F. Beerkens, J. Nicolas, M. Satish, Davis Jones, M. Demirhan, G. Dangas   +6 more
semanticscholar   +1 more source

Treatment of the Carotid In-stent Restenosis: A Systematic Review

Frontiers in Neurology, 2021
Background and Purpose: In-stent restenosis (ISR) after carotid artery stent (CAS) is not uncommon. We aimed to evaluate therapeutic options for ISR after CAS.
Hao Huang, Lingshan Wu, Yinping Guo, Yi Zhang, Jing Zhao, Zhi-yuan Yu, Xiang Luo   +6 more
semanticscholar   +1 more source

Predictors of Diffuse In-Stent Restenosis, a Retrospective Analysis in a Subset of Egyptian Population

Majalah Kardiologi Indonesia
Background: Despite the fact that DES implantation has decreased theincidence of ISR dramatically, it is not negligible. Diffuse ISR is associated withpoor outcomes.
Ahmed Mahmoud El Amrawy, Mohamed Ibrahim Loutfi, Ahmed Mokhtar Abd El Azeem   +2 more
doaj   +1 more source